Regentatlantic Capital LLC Boston Scientific Corp Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 29,939 shares of BSX stock, worth $2.51 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

29,939

Previous 33,771 11.35%

Holding current value

$2.51 Million

Previous $1.26 Million 7.86%

% of portfolio

0.03%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $140,672 - $420,217	-3,832 Reduced 11.35%	29,939 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $9,972 - $13,329	283 Added 0.85%	33,771 $1.26 Million
Q1 2022 May 02, 2022	SELL	$40.9 - $45.1 $267,690 - $295,179	-6,545 Reduced 16.35%	33,488 $1.48 Million
Q4 2021 Jan 27, 2022	BUY	$38.07 - $44.87 $298,735 - $352,094	7,847 Added 24.38%	40,033 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $1,772 - $1,972	43 Added 0.13%	32,186 $1.4 Million
Q2 2021 Aug 12, 2021	BUY	$38.58 - $44.24 $178,625 - $204,831	4,630 Added 16.83%	32,143 $1.37 Million
Q1 2021 Apr 29, 2021	BUY	$35.27 - $39.67 $85,318 - $95,961	2,419 Added 9.64%	27,513 $1.06 Million
Q4 2020 Feb 04, 2021	BUY	$33.15 - $41.97 $105,251 - $133,254	3,175 Added 14.49%	25,094 $902,000
Q3 2020 Oct 13, 2020	BUY	$34.44 - $42.23 $177,641 - $217,822	5,158 Added 30.77%	21,919 $838,000
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $232,161 - $300,755	7,690 Added 84.78%	16,761 $588,000
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $234,303 - $414,635	9,071 New	9,071 $296,000

Others Institutions Holding BSX

# of Institutions

1,449

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $120B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Boston Scientific Corp Transaction History